Angiolab

Angiolab is a biotech company in Daejeon, South Korea, founded in 1999. It has raised $7.1M across 1 round, most recently a $7.1M Seed in 2006 (est.).

Headquarters
Daejeon
Employees
11–50
Founded
1999
Business Model
B2B
Total Funding
$7.1M
Last Round
$7.1M SeedJan 2006
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

AngioLab, Inc. is a South Korean biotechnology company specializing in the discovery and development of angiogenesis inhibitors and stimulators for therapeutic applications. The company develops pharmaceutical products targeting ophthalmic disorders (including macular degeneration), gastrointestinal conditions, psoriasis, obesity, and metabolic diseases, as well as cosmetic and functional food applications. With over 102 patents and a focus on the molecular mechanisms of angiogenesis — the process of new blood vessel formation — AngioLab conducts clinical trials and partners with pharmaceutical companies to advance its pipeline. The company is publicly listed on the Korean KOSDAQ exchange (stock symbol: 251280) and is headquartered in Daejeon, South Korea (Yuseong-gu district). Its research spans angiogenesis modulation across both inhibitory (cancer, AMD) and stimulatory (wound healing, ischemia) therapeutic axes.

Summary

It lists 11–50 employees. It has raised $7.1M in total across 1 round, most recently a $7.1M Seed round in 2006 (est.). Investors include Korean Development Bank.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed Round2006 (est.)
$7.1M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Angiolab on Indexed.vc
<a href="https://indexed.vc/companies/angiolab"><img src="https://indexed.vc/api/badge/company/angiolab" alt="Angiolab on Indexed.vc" width="260" height="76" /></a>